ユタにおける急性リンパ性白血病の臨床試験
ユタ内の拠点で、急性リンパ性白血病に関する10件の研究が参加者を募集しています。
ユタ内の都市
公式研究テキスト（英語）
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
- Huntsman Cancer Institute, University of Utah, Salt Lake City
被験者募集中
1歳〜25歳 · 全性別 · 2026/10/01更新 · NCT05621291A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- Primary Children's Hospital, Salt Lake City
被験者募集中第1相
0歳〜18歳 · 全性別 · 2026/09/16更新 · NCT06173518Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies
- Huntsman Cancer Institute, Salt Lake City
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/26更新 · NCT06227026The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Primary Children's Hospital, Salt Lake City
被験者募集中第1/2相
22歳以下 · 全性別 · 2026/08/25更新 · NCT04726241Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Primary Children's Hospital, Salt Lake City
被験者募集中第2相
7歳〜25歳 · 全性別 · 2026/08/19更新 · NCT05082519A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Utah, Salt Lake City
被験者募集中観察研究
全年齢 · 全性別 · 2026/07/06更新 · NCT01351545TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- University of Utah Huntsman Cancer Institute, Salt Lake City
被験者募集中第1/2相
1歳以下 · 全性別 · 2026/06/03更新 · NCT05848687Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- University of Utah, Salt Lake City
被験者募集中第1相
13歳以上 · 全性別 · 2026/05/05更新 · NCT04771572A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare, Salt Lake City
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/03/24更新 · NCT04988555Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Primary Children's Hospital, Salt Lake City
被験者募集中第1相
1歳〜21歳 · 全性別 · 2024/12/06更新 · NCT05476770ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。